Bacterial Pneumonia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial; Community-acquiredInterventions: Drug: Ceftaroline; Drug: LevofloxacinSponsors: Gary E. Stein, Pharm.D.; Forest LaboratoriesCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2012 Category: Research Source Type: clinical trials
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial; Community-acquiredInterventions: Drug: Ceftaroline; Drug: LevofloxacinSponsors: Michigan State University; Gary E. Stein, Pharm.D.; Forest LaboratoriesRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2012 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions: Community-Acquired Bacterial Pneumonia; Lung Infection of Individual Not Recently HospitalizedInterventions: Drug: Ceftaroline; Drug: CeftriaxoneSponsors: AstraZeneca; Forest LaboratoriesCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2011 Category: Research Source Type: clinical trials